Go to the Scleroderma Foundation's home page.
Lee Shapiro, M.D., FACP, The Center for Rheumatology, LLP, Albany, New York Robert Simms, M.D., Boston University School of Medicine Carol Feghali-Bostwick, Ph.D., Assistant Professor of Medicine, University of Pittsburgh Thomas A. Medsger, M.D., Jr., Gerald P. Rodnan Professor of Medicine at the University of Pittsburgh School of Medicine
Coping with Scleroderma
CREST

Gastrointestinal Involvement

Kidney Involvement
Localized Scleroderma
Lung Involvement
Oral, Facial, and Dental Problems
Other Medical Topics Related to Scleroderma
Raynaud's Phenomenon
Research and Treatment Advances
Sexuality in Scleroderma
Sjögren's Syndrome
Education Home

 

Printer Friendly

Tell a friend:

Raynaud's Phenomenon and Scleroderma

By Richard Silver, M.D., Professor of Medicine, Medical University of South Carolina (originally published in "Scleroderma Voice," 2002 Issue #1)

Richard Silver, M.D.

Richard Silver, M.D.

Question: I have been diagnosed with Raynaud's phenomenon. I recently learned that there is a close link between Raynaud's and scleroderma. However, I understand there may be a delay of as long as 20 years from the first signs of Raynaud's until the appearance of other signs of scleroderma.

Answer: A close relationship between Raynaud's phenomenon and scleroderma does indeed exist. About 95% of all scleroderma patients experience Raynaud's phenomenon (tri-color changes in the fingers and/or toes induced by cold exposure).

On the other hand (no pun intended), Raynaud's phenomenon is a common condition in the adult population, and most people with Raynaud's phenomenon are otherwise healthy. Only about 5% of them have (or will subsequently develop) a connective-tissue disease such as scleroderma.

Two tests seem to have value for determining which Raynaud's phenomenon sufferers may be at risk:

  1. A blood test for antinuclear antibodies, especially tests for specific auto antibodies such as anti-centromere or anti-scleroderma-70 antibodies; and
  2. Nailfold capillary microscopy.

The former is readily available and can be ordered by your primary care doctor.

The latter is a non-invasive study of the small blood vessels in your skin, which often requires consultation with a rheumatologist trained to conduct such examinations.

300 Rosewood Drive, Suite 105, Danvers, MA 01923 · Phone 978-463-5843 · 800-722-HOPE (4673)
Home  | Donate | Contact UsFree eLetter | Membership | National Conference | Message BoardStoreCalendar
Careers
Search Site

© Copyright 2001-2008 Scleroderma Foundation. All Rights Reserved. Disclaimer. Privacy Policy.

Last Updated 5/13/08

Webmaster